Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands) - 1 Oct 2009

Hosokawa Shinobu, Toyooka Shinichi, Fujiwara Yoshiro, Tokumo Masaki, Soh Junichi, Takigawa Nagio, Hotta Katsuyuki, Yoshino Tadashi, Date Hiroshi, Tanimoto Mitsune, Kiura Katsuyuki

Abstract excerpt

PURPOSE: Translational approach is essentially needed to return the achievement of basic researches to oncological practice. The molecular associations among EGFR mutation and the components of EGFR signaling pathways have been extensively studied in laboratory experiments, although were still controversial. Moreover, the impact of downstream signaling of EGFR on clinical features in patients with non-small cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gefitinib

Share to Genes, erbB-1

Share to Proto-Oncogene Proteins c-akt

Share to Quinazolines

Source

Identifiers

PMID: 19185949
DOI: 10.1016/j.lungcan.2009.01.005

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer.PMID 19185949Read ↗

Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancerSemantic proximity Read ↗

Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutation.Semantic proximity Read ↗

New development of inhibitors targeting the PI3K/AKT/mTOR pathway in personalized treatment of non-small-cell lung cancer.Semantic proximity Read ↗

L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.Semantic proximity Read ↗

Correlation between EGFR gene mutation pattern and Akt phosphorylation in pulmonary adenocarcinomas.Semantic proximity Read ↗

An analysis of the gene interaction networks identifying the role of PARP1 in metastasis of non-small cell lung cancerSemantic proximity Read ↗

ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer.Semantic proximity Read ↗

Role of tyrosine kinase-independent phosphorylation of EGFR with activating mutation in cisplatin-treated lung cancer cells.Semantic proximity Read ↗

Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions.Semantic proximity Read ↗

High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in TaiwanSemantic proximity Read ↗

Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations.Semantic proximity Read ↗

Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.